Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
Running, not enrolling · Not applicable
Conditions studied: Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
In brief
This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).
Key facts
- Study ID
- NCT05462145
- Run by
- Kardium Inc.
- People needed
- 549
- Starts
- 2023-03-09
- Expected to finish
- 2026-09-01
- Last updated by the study team
- 2026-01-30
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Grandview Medical Center — Birmingham, Alabama, United States
- St. Bernards Medical Center — Jonesboro, Arkansas, United States
- Sutter Health - California Pacific Medical Center — San Francisco, California, United States
- St. Vincent's Medical Center — Jacksonville, Florida, United States
- Mercy Hospital — Miami, Florida, United States
- Johns Hopkins — Baltimore, Maryland, United States
- Beaumont Hospital — Royal Oak, Michigan, United States
- Mt. Sinai Hospital, Guggenheim Pavilion — New York, New York, United States
- Cleveland Clinic — Cleveland, Ohio, United States
- Doylestown Hospital — Doylestown, Pennsylvania, United States
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Texas Cardiac Arrhythmia Research Foundation — Austin, Texas, United States
- St.Paul's Hospital — Vancouver, British Columbia, Canada
- McGill University Health Centre — Montreal, Quebec, Canada
- Motol and Homolka University Hospital — Prague, Czechia
- Heart and Diabetes Center NRW — Bad Oeynhausen, Germany
- Charité Campus Virchow Clinic — Berlin, Germany
- Westpfalz-Klinikum GmbH Kaiserslautern — Kaiserslautern, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.